| CAS Number |
Product Names |
Molecular Formula |
|
88920-78-9
|
1-(3,4-DIMETHOXYPHENYL)ETHAN-1-ONE OXIME SDS |
C10H13NO3 |
|
88920-24-5
|
(4-Methoxybenzyloxy)acetic acid SDS |
C10H12O4 |
|
88919-89-5
|
N,2'-Dimethyl-2,3'-bi-indolyl |
C18H16N2 |
|
88919-85-1
|
N'-Methyl-2,3'-bi-indolyl |
C17H14N2 |
|
88919-51-1
|
N-DesMethyl SuMatriptan SDS |
C13H18N3O2S |
|
88919-22-6
|
3-(2-Aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide SDS |
C12H17N3O2S |
|
88918-84-7
|
4-Amino-N-methylbenzenemethanesulfonamide hydrochloride SDS |
C8H13ClN2O2S |
|
88918-76-7
|
3-(CyanoMethyl)-N-Methyl-1H-indole-5-MethanesulfonaMide |
C12H13N3O2S |
|
88918-36-9
|
2(3H)-Isoxazolecarbonylchloride,5-(chloromethyl)-3-oxo-(9CI) SDS |
C5H3Cl2NO3 |
|
88917-26-4
|
Oxo alcohol citrate |
|
| MW: |
|
88917-22-0
|
Di(propylene glycol) methyl ether acetate SDS |
C9H18O4 |
|
88917-25-3
|
Poly(oxy-1,4-butanediyl), .alpha.-hydro-.omega.-hydroxy-, polymer with 2,4-diisocyanato-1-methylbenzene, 2-hydroxyethyl acrylate-blocked poly(oxy-1,4-butanediyl), alpha-hydro- omega -hydroxy-, polymer with 2,4-diisoc |
|
| MW: |
|
88917-24-2
|
Butanediamide, N,N-bis3-(9Z)-9-octadecenylaminopropyl-, polybutenyl derivs. |
C46H90N4O2 |
|
88917-11-7
|
2-Chlorothiazole-5-sulfonyl chloride SDS |
C3HCl2NO2S2 |
|
88915-70-2
|
borosarcosine N-ethylamide SDS |
C4H13 B N2 O |
|
88915-69-9
|
DIMETHYLAMINE-BORANE CARBOXYLIC ACID-N-ETHYL AMIDE SDS |
C5H15 B N2 O |
|
88915-64-4
|
MOGROSIDE IV SDS |
C54H92O24 |
|
88915-34-8
|
4-PiperidinaMine, 3-Methyl-1-(phenylMethyl)-, (3R,4S) |
C13H20N2 |
|
88915-33-7
|
4-PiperidinaMine, 3-Methyl-1-(phenylMethyl)-, trans- (9CI) |
C13H20N2 |
|
88915-31-5
|
(2-Nitro-phenyl)-piperidin-4-yl-aMine hydrochloride |
C11H16ClN3O2 |
|
88915-26-8
|
(1-Benzyl-4-piperidinyl)methylamine SDS |
C13H20N2 |
|
88914-44-7
|
Methanesulfonamide, N-(4-((4,5-dimethoxy-9-acridinyl)amino)-3-(dimethy lamino)phenyl)- SDS |
C24H26 N4 O4 S |
|
88914-43-6
|
Methanesulfonamide, N-(4-((4,5-dimethyl-9-acridinyl)amino)-3-(dimethyl amino)phenyl)- SDS |
C24H26 N4 O2 S |
|
88914-42-5
|
Methanesulfonamide, N-(3-(dimethylamino)-4-((3-methoxy-5-methyl-9-acri dinyl)amino)phenyl)- SDS |
C24H26 N4 O3 S |
|
88914-40-3
|
Methanesulfonamide, N-(4-((3-chloro-5-methoxy-9-acridinyl)amino)-3-(di methylamino)phenyl)- SDS |
C23H23 Cl N4 O3 S |
|
88914-38-9
|
Methanesulfonamide, N-(3-(dimethylamino)-4-((3-fluoro-5-methyl-9-acrid inyl)amino)phenyl)- SDS |
C23H23 F N4 O2 S |
|
88914-39-0
|
Methanesulfonamide, N-(4-((3-chloro-5-methyl-9-acridinyl)amino)-3-(dim ethylamino)phenyl)- SDS |
C23H23 Cl N4 O2 S |
|
88912-57-6
|
pyrrofolic acid SDS |
C23H21 N7 O7 |
|
88912-27-0
|
3-Chloroisonicotinic acid SDS |
C6H4ClNO2 |
|
88912-26-9
|
2,5-Dichloroisonicotinic acid SDS |
C6H3Cl2NO2 |
|
88912-25-8
|
4,6-Dichloro-2-pyridinecarboxylic acid SDS |
C6H3Cl2NO2 |
|
88912-23-6
|
2,6-Difluoro-4-pyridinecarboxylic acid SDS |
C6H3F2NO2 |
|
88912-24-7
|
2-Pyridinecarboxylic acid, 5,6-dichloro- SDS |
C6H3Cl2NO2 |
|
88912-22-5
|
5-CHLORO-2-METHOXY-ISONICOTINIC ACID |
C7H6ClNO3 |
|
88912-21-4
|
6-CHLORO-4-METHOXY-PYRIDINE-2-CARBOXYLIC ACID SDS |
C7H6ClNO3 |
|
88911-35-7
|
[3aS,(+)]-1,3aα,4,5,6,6aα-Hexahydro-5β-hydroxy-6α-[(1E,3S)-3-hydroxy-1-octenyl]pentalene-2-pentanoic acid |
C21H34O4 |
|
88909-96-0
|
4-(N-(1,8-NAPHTHALIMIDO))-N-BUTYRIC ACID SDS |
C16H13NO4 |
|
88909-82-4
|
9,10-DIHYDRO-1-BENZO[A]PYRENE-7(8H)-ONE OXIME SDS |
C20H15NO |
|
88908-87-6
|
Bicyclo[3.1.0]hexane-1-carboxylic acid, 2-methylene-, methyl ester (9CI) SDS |
C9H12O2 |
|
88908-15-0
|
L-Alanine,N-[(1-methylhydrazino)carbonyl]-(9CI) |
C5H11N3O3 |
|
88907-86-2
|
2-Cyclopentene-1-carboxylic acid, 1,2,5-trimethyl-, trans- (9CI) |
C9H14O2 |
|
88907-48-6
|
BAFILOMYCIN B2 SDS |
C45H67NO13 |
|
88905-76-4
|
4-CHLORO-1,2,5-THIADIAZOL-3-OL SDS |
C2HClN2OS |
|
88903-93-9
|
2,3-Naphthalenediol,6-(dimethylamino)-5,6,7,8-tetrahydro-,(S)-(9CI) |
C12H17NO2 |
|
88903-69-9
|
XESTOSPONGIN C SDS |
C28H50N2O2 |
|
88903-92-8
|
2,3-Naphthalenediol,6-(dimethylamino)-5,6,7,8-tetrahydro-,(R)-(9CI) |
C12H17NO2 |
|
88902-03-8
|
(4aS,5S,8aS)-1,2,3,4,4a,5,8,8a-Octahydro-1,1,4aβ,6-tetramethyl-5β-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-triene-1-yl]naphthalene |
C30H50 |
|
88901-69-3
|
alterporriol B SDS |
C32H26O13 |
|
88901-46-6
|
Mogroside I A1 |
|
|
88901-45-5
|
Mogroside II A2 SDS |
C42H72O14 |
|
88901-44-4
|
Mogroside II A1 |
C42H72 O14 |
|
88901-42-2
|
Mogroside ⅢA1 SDS |
C48H82O19 |
|
88901-41-1
|
Mogroside IVa |
C54H92O24 |
|
88901-39-7
|
Mogroside I E1 |
|
|
88901-38-6
|
MogrosideIIE SDS |
C42H72O14 |
|
88901-36-4
|
Mogroside V SDS |
C60H102O29 |
|
88901-37-5
|
Mogroside Ⅲe SDS |
C48H82O19 |
|
88899-85-8
|
(2E)-3-[4-(Methylsulfonyl)phenyl]propenoic acid |
C10H10O4S |
|
88899-70-1
|
2-nitroso-6-methyldipyrido(1,2-a-3',2'-d)imidazole |
C11H8 N4 O |
|
88899-62-1
|
ALTERPERYLENOL SDS |
C20H14O6 |
|
88899-61-0
|
solanapyrone A SDS |
C18H22O4 |
|
88899-60-9
|
solanapyrone B SDS |
C18H24O4 |
|
88899-59-6
|
4-[(2-Hydroxyethyl)amino]-6-[(1R)-1,2,4aα,5,6,7,8,8aα-octahydro-2β-methylnaphthalen-1α-yl]-2-oxo-2H-pyran-3-carbaldehyde |
C19H25NO4 |
|
88899-58-5
|
21-O-Acetyl-21-O-de(3-carboxy-1-oxo-2-propenyl)-2-demethyl-2-methoxy-24-methylhygrolidin |
C37H60O10 |
|
88899-57-4
|
7-O,21-O-Diacetyl-21-O-de(3-carboxy-1-oxo-2-propenyl)-2-demethyl-2-methoxy-24-methylhygrolidin |
C39H62O11 |
|
88899-55-2
|
BAFILOMYCIN A1 SDS |
C35H58O9 |
|
88899-56-3
|
BAFILOMYCIN B1 SDS |
C44H65NO13 |
|
88899-54-1
|
19-O-Methyl-21-O-de(3-carboxy-1-oxo-2-propenyl)-2-demethyl-2-methoxy-24-methylhygrolidin |
C36H60O9 |
|
88899-52-9
|
49-Chloro-7-O-de(α-D-mannopyranosyl)avoparcin α |
C83H91Cl2N9O31 |
|
88899-31-4
|
3-(3-Bromo-2-nitrophenyl)-1H-pyrrole |
C10H7BrN2O2 |
|
88899-22-3
|
BZ-PHE-VAL-ARG-AMC SDS |
C37H43N7O6 |
|
88899-17-6
|
(2S,3R,4R,4aα,8aβ)-4-Acetyl-3,4,4a,5,6,7,8,8a-octahydro-2β,7β-dihydroxy-2α,4,5α,7α-tetramethyl-3-[(R)-1-methylpropyl]-1(2H)-naphthalenone |
C20H34O4 |
|
88899-16-5
|
(2S,4aα,8aβ)-3,4,4a,5,6,7,8,8a-Octahydro-2,7β-dihydroxy-7α-(hydroxymethyl)-4α-(3-hydroxy-1-oxopropyl)-2,4β,5α-trimethyl-3α-[(R)-1-methylpropyl]-1(2H)-naphthalenone |
C21H36O6 |
|
88899-15-4
|
L-Alanine, N-(3-cyclopenten-1-yl)- (9CI) |
C8H13NO2 |
|
88898-17-3
|
ATRIAL NATRIURETIC FACTOR (1-28) (RAT) SDS |
C128H205N45O39S2 |
|
88899-00-7
|
2'-deoxyoxanosine SDS |
C10H12 N4 O5 |
|
88895-48-1
|
Miranol JEM Conc. |
|
| MW: |
|
88895-34-5
|
beta-latrotoxin |
|
|
88894-91-1
|
GRF (1-44) (BOVINE) |
C220H366N72O66S1 |
|
88895-19-6
|
CYTODEX 3 |
|
|
88894-02-4
|
MALONONITRILE, [2-(1-ETHYLNAPHTHO[1,2-D]THIAZOLIN-2-YLIDENE)ETHYLIDENE]- SDS |
C18H13N3S |
|
88893-76-9
|
Pyrazole-3(or 5)-carboxaldehyde, 5(or 3)-methyl-4-nitro- (7CI) |
C5H5N3O3 |
|
88892-89-1
|
5H-s-Triazolo[4,3-b]-s-triazole, 5-acetyl-6-methyl- (7CI) SDS |
C6H7N5O |
|
88892-84-6
|
Succinimide, thio-N-2,4-xylyl- (7CI) SDS |
C12H13NOS |
|
88891-75-2
|
PYRIMIDINE-5-CARBOTHIOIC ACID AMIDE SDS |
C5H5N3S |
|
88892-83-5
|
2-Pyrrolidinone, 1-(2,5-dimethylphenyl)-5-thioxo- |
C12H13NOS |
|
88891-74-1
|
4-Pyrimidinecarboxamide, thio- (6CI,7CI) SDS |
C5H5N3S |
|
88891-38-7
|
FORMALDEHYDE, [3H] SDS |
CHOT |
|
88891-55-8
|
2-(1,3,5-Dithiazinan-5-yl)ethanol SDS |
C5H11NOS2 |
|
88891-36-5
|
Potassium S-(2,5-dihydroxyphenyl) thiosulfate |
C6H5KO5S2 |
|
88890-66-8
|
6-Methyl-5-nitropyrimidine-2,4(1H,3H)-dione |
C5H5N3O4 |
|
88889-14-9
|
Fosinopril sodium SDS |
C30H46NNaO7P |
|
88889-92-3
|
BETA-(2-DIMETHYLAMINOETHYLTHIO)-PHENETHYL ALCOHOL SDS |
C12H19NOS |
|
88889-00-3
|
N,N-DIMETHYLANILINE-D3 (N-METHYL-D3) SDS |
C8H8D3N |
|
88887-99-4
|
2-diazo-3-trifluoropropionyloxy geranyl pyrophosphate SDS |
C13H19 F3 N2 O9 P2 |
|
88887-87-0
|
1-Methylcyclopropylamine hydrochloride SDS |
C4H10ClN |
|
88883-84-5
|
2-(4-METHYL-1H-IMIDAZOL-2-YL)-ETHYLAMINE DIHYDROCHLORIDE SDS |
C6H13Cl2N3 |
|
88887-42-7
|
5-hexadecyl methotrexate SDS |
C36H54N8O5 |
|
88883-73-2
|
2-(4-METHYL-1H-IMIDAZOL-2-YL)-ETHYLAMINE DIHYDROCHLORIDE SDS |
C6H13Cl2N3 |
|
88881-74-7
|
Ethyl 2-(4-acetamidophenyl)sulfonylacetate SDS |
C12H15NO5S |
